The pharmacokinetics of cinacalcet are unaffected following consumption of high- and low-fat meals

American Journal of Therapeutics

Volumn 14, Issue 3, 2007, Pages 235-240

  Padhi, Desmond ^a   Salfi, Margaret ^a   Harris, Robert Z ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CINACALCET;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CALORIC INTAKE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIETARY INTAKE; DRUG SAFETY; DYSPEPSIA; FEMALE; FOOD; FOOD DRUG INTERACTION; HEADACHE; HUMAN; HUMAN EXPERIMENT; LIPID DIET; MALE; NAUSEA; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ADULT; AREA UNDER CURVE; CROSS-OVER STUDIES; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FASTING; FEMALE; HALF-LIFE; HUMANS; MALE; METABOLIC CLEARANCE RATE; NAPHTHALENES;

EID: 34249100204     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000212703.71625.26     Document Type: Article

References (11)

1. Nemeth EF, Heaton WH, Miller M, et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther. 2004;308:627-635.
2. Lindberg JS, Culleton B, Wong G, et al. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol. 2005;16:800-807.
3. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350:1516-1525.
4. Shoback DM, Bilezikian JP, Turner SA, et al. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab. 2003;88:5644-5649.
5. Peacock M, Bilezikian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2005;90:135-141.
6. Silverberg SJ, Faiman C, Bilezikian JP, et al. Cinacalcet HCl effectively treats hypercalcemia in patients with parathyroid carcinoma. J Bone Miner Res. 2004;19:S103.
7. Singh BN, Malhotra BK. Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy. Clin Pharmacokinet. 2004;43:1127-1156.
8. Harris RZ, Jang GR, Tsunoda S. Dietary effects on drug metabolism and transport. Clin Pharmacokinet. 2003;42:1071-1088.
9. Center for Drug Evaluation and Research. Guidance for industry. In: United States Department of Health and Human Services, ed. Food-effect Bioavailability and Fed Bioequivalence Studies. U.S. Department of Health and Human Services. Rockville, MD: Food and Drug Administration; 2002.
10. Lin HC, Kim BH, Elashoff JD, et al. Gastric emptying of solid food is most potently inhibited by carbohydrate in the canine distal ileum. Gastroenterology. 1992;102:793-801.
11. Fleisher D, Li C, Zhou Y, et al. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet. 1999;36:233-254.